Lysyl oxidase G473A polymorphism is associated with increased risk of coronary artery diseases

DNA and Cell Biology

Volumn 30, Issue 12, 2011, Pages 1033-1037

  Ma, Lan ^a   Song, Haihan ^b   Zhang, Meiyan ^a   Zhang, Daifu ^a  

^a TONGJI UNIVERSITY   (China)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN LYSINE 6 OXIDASE;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; CHINA; CHROMOSOMES, HUMAN, PAIR 5; CODON; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-LYSINE 6-OXIDASE; RISK;

EID: 82955165795     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1261     Document Type: Article

References (30)

1. Badimon, L. (2001). Atherosclerosis and thrombosis: lessons from animal models. Thromb Haemost 86, 356-365. (Pubitemid 32672855)
2. Boak, A.M., Roy, R., Berk, J., Taylor, L., Polgar, P., Goldstein, R.H., and Kagan, H.M. (1994). Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor-beta 1 and prostaglandin E2. Am J Respir Cell Mol Biol 11, 751-755.
3. Casani, L., Sanchez-Gomez, S., Vilahur, G., and Badimon, L. (2005). Pravastatin reduces thrombogenicity by mechanisms beyond plasma cholesterol lowering. Thromb Haemost 94, 1035-1041. (Pubitemid 41645946)
4. Ferns, G.A., Raines, E.W., Sprugel, K.H., Motani, A.S., Reidy, M.A., and Ross, R. (1991). Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253, 1129-1132. (Pubitemid 21917260)
5. Fogelgren, B., Polgar, N., Szauter, K.M., Ujfaludi, Z., Laczko, R., Fong, K.S., and Csiszar, K. (2005). Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J Biol Chem 280, 24690-24697. (Pubitemid 40934558)
6. Gacheru, S.N., Thomas, K.M., Murray, S.A., Csiszar, K., Smith-Mungo, L.I., and Kagan, H.M. (1997). Transcriptional and post-transcriptional control of lysyl oxidase expression in vascular smooth muscle cells: effects of TGF-b1 and serum deprivation. J Cell Biochem 65, 395-407. (Pubitemid 27190694)
7. Green, R.S., Lieb, M.E., Weintraub, A.S., Gacheru, S.N., Rosen-field, C.L., Shah, S., Kagan, H.M., and Taubman, M.B. (1995). Identification of lysyl oxidase and other platelet-derived growth factor-inducible genes in vascular smooth muscle cells by differential screening. Lab Invest 73, 476-482.
8. Hornstra, I.K., Birge, S., Starcher, B., Bailey, A.J., Mecham, R.P., and Shapiro, S.D. (2002). Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem 278, 14387-14393.
9. Huffman, M.D., Curci, J.A., Moore, G., Kerns, D.B., Starcher, B.C., and Thompson, R.W. (2000). Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Surgery 128, 429-438.
10. Ignotz, R.A., and Massague, J. (1986). Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261, 4337-4345. (Pubitemid 17198877)
11. Kagan, H.M., and Li, W. (2003). Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 88, 660-672. (Pubitemid 36258816)
12. Khan, R., Agrotis, A., and Bobik, A. (2007). Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury. Cardiovasc Res 74, 223-234. (Pubitemid 46517511)
13. Kingston, P.A., Sinha, S., David, A., Castro, M.G., Lowenstein, P.R., and Heagerty, A.M. (2001). Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition. Circulation 104, 2595-2601. (Pubitemid 33104799)
14. Levitzki, A. (2005). PDGF receptor kinase inhibitors for the treatment of restenosis. Cardiovasc Res 65, 581-586. (Pubitemid 40142661)
15. Lucero, H.A., and Kagan, H.M. (2006). Lysyl oxidase: an oxi-dative enzyme and effector of cell function. Cell Mol Life Sci 63, 2304-2316. (Pubitemid 44653041)
16. Maki, J.M., Rasanen, J., Tikkanen, H., Sormunen, R., Makikallio, K., Kivirikko, K.I., and Soininen, R. (2002). Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction and perinatal death in mice. Circulation 106, 2503-2509. (Pubitemid 35278809)
17. Maki, J.M., Sormunen, R., Lippo, S., Kaarteenaho-Wiik, R., Soi-ninen, R., and Myllyharju, J. (2005). Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. Am J Pathol 167, 927-936. (Pubitemid 41416246)
18. Min, C., Yu, Z., Kirsch, K.H., Zhao, Y., Vora, S.R., Trackman, P.C., Spicer, D.B., Rosenberg, L., Palmer, J.R., and Sonenshein, G.E. (2009). A loss-of-function polymorphism in the propep-tide domain of the LOX gene and breast cancer. Cancer Res 69, 6685-6693.
19. Minamino, T., Miyauchi, H., Yoshida, T., Tateno, K., and Ko-muro, I. (2004). The role of vascular cell senescence in atherosclerosis: antisenescence as a novel therapeutic strategy for vascular aging. Curr Vasc Pharmacol 2, 141-148. (Pubitemid 38855022)
20. Nabel, E.G., Shum, L., Pompili, V.J., Yang, Z.Y., San, H., Shu, H.B., Liptay, S., Gold, L., Gordon, D., and Derynck, R. (1993). Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA 90, 10759-10763. (Pubitemid 23347122)
21. Nakashima, Y., and Sueishi, K. (1992). Alteration of elastic architecture in the lathyritic rat aorta implies the pathogenesis of aortic dissecting aneurysm. Am J Pathol 140, 959-969.
22. Palamakumbura, A.H., Jeay, S., Guo, Y., Pischon, N., Sommer, P., Sonenshein, G.E., and Trackman, P.C. (2004). The pro-peptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. J Biol Chem 279, 40593-40600. (Pubitemid 39287651)
23. Ren, J., Wu, X., He, W., Shao, J., Cheng, B., and Huang, T. (2011). Lysyl oxidase 473 g〉a polymorphism and breast cancer susceptibility in Chinese Han population. DNA Cell Biol 30, 111-116.
24. Rodríguez, C., Martínez-González, J., Raposo, B., Alcudia, J.F., Guadall, A., and Badimon, L. (2008). Regulation of lysyl oxi-dase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases. Cardiovasc Res 79, 7-13. (Pubitemid 351881945)
25. Rodríguez, C., Raposo, B., Martínez-González, J., Casaní, L., and Badimon, L. (2002). Low density lipoproteins down-regulates lysyl oxidase in vascular endothelial cells and the arterial wall. Arterioscler Thromb Vasc Biol 22, 1409-1414.
26. Shanley, C.J., Gharaee-Kermani, M., Sarkar, R., Welling, T.H., Kriegel, A., Ford, J.W., Stanley, J.C., and Phan, S.H. (1997). Transforming growth factor-beta 1 increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells. J Vasc Surg 25, 446-452. (Pubitemid 27136968)
27. Sibon, I., Sommer, P., Lamaziere, J.M., and Bonnet, J. (2005). Lysyl oxidase deficiency: a new cause of human arterial dissection. Heart 91, e33.
28. Weissen-Plenz, G., Eschert, H., Volker, W., Sindermann, J.R., Beissert, S., Robenek, H., Scheld, H.H., and Breithardt, G. (2008). Granulocyte macrophage colony-stimulating factor deficiency affects vascular elastin production and integrity of elastic lamellae. J Vasc Res 45, 103-110. (Pubitemid 351651295)
29. Yamamoto, K., Morishita, R., Tomita, N., Shimozato, T., Naka-gami, H., Kikuchi, A., Aoki, M., Higaki, J., Kaneda, Y., and Ogihara, T. (2000). Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ri-bozyme strategy to treat cardiovascular disease. Circulation 102, 1308-1314.
30. Yoshimura, K., Aoki, H., Ikeda, Y., Furutani, A., Hamano, K., and Matsuzaki, M. (2006). Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase in mice. Ann N Y Acad Sci 1085, 74-81. (Pubitemid 47092002)